Physicians' Academy for Cardiovascular Education

The Clinical Unmet need in the patient with Diabetes and ACS

Aug. 26, 2017 - Barcelona, Spain - Kausik Ray, MD Imperial College London United Kingdom - PACE-CME symposium held at ESC 2017

This lecture was part of a CME accredited symposium: 'Managing Diabetes & CVD: Is epigenetics a new way forward?' held at ESC 2017 in Barcelona

Video navigation menu

  • Diabetes is an important CV risk factor that shortens life expectancy 0:16
  • Lipid-lowering and BP-reduction yield more benefit in diabetes than glucose-lowering 2:23
  • Some newer antidiabetic drugs may have a broader effect than glucose lowering 4:51
  • Considering the residual risk, inflammation and the perturbed vasculature may be the next pathways to target in DM 5:52

Educational information

The educational objectives of this symposium were to:

Disclosures

Kausik Ray, MD, is cardiologist, and Professor of Public Health/Honorary Consultant Cardiologist at Imperial College London, United Kingdom

CME Accreditation

This programme was accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit(s).

Funding

This symposum was supported by an unrestricted educational grant provided by Resverlogix